VOTRIENT 200 MG
VOTRIENT 200 MG
Categories: Anti-Diabetic, BEST SELLER, Breast Cancer, Colorectal Cancer, Diabetic, Endometrial Cancer, Liver Cancer, Lymphoma, ONCOLOGY PRODUCTS, Ovarian Cancer, Pancreatic Cancer, Peritoneal Cancer, Primary Biliary Cirrhosis, Prostate Cancer, Renal Cell Carcinoma, Rheumatoid Arthritis
Tags: Afatinib Dimaleate INN, ALECNIB 150 MG, AXINIX, BARICINIX 4 MG, Baricinix Tablet, Beacon Pharmaceuticals Ltd., Cancer Medicine in Bangladesh, Oncology Medicine Supplier, Oncology Medicine Supplier in Bangladesh, Oncology Medicines in Bangladesh, VOTRIENT, VOTRIENT 200 MG
Reviews (0)
Be the first to review “VOTRIENT 200 MG” Cancel reply
Shipping & Delivery
MAECENAS IACULIS
Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing
Related products
ELOPAG 25 MG
Elopag Tablet Eltrombopag Olamine 25 mg Everest Pharmaceuticals Ltd. Indications Eltrombopag Olamine is indicated in Chronic Immune (Idiopathic) Thrombocytopenia, Chronic Hepatitis
BARICINIX 2 MG
Product Description: Baricitinib is indicated for the treatment of moderate to severely active rheumatoid arthritis in adult patients who have
CRIZOCENT 250 MG
Presentation Crizocent 250: Each capsule contains Crizotinib INN 250 mg Description Crizotinib is an inhibitor of receptor tyrosine kinases including
ELTROM 25 MG
DESCRIPTION ELTROM Eltrombopag 25MG Julphar Bangladesh Ltd. Composition: Eltrom Tablet: Each film coated tablet contains Eltrombopag Olamine INN equivalent to
CABOZANIX 20 MG
Product Description: Cabozanix is a multiple Tyrosine Kinase inhibitor that is indicated for the treatment of Renal Cell Carcinoma and
Elbonix 50
COMPOSITION Elbonix 50 tablet : Each film coated tablet contains EltrombopagOlamine INN equivalent to Eltrombopag 50 mg. Therapeutic class: Hematopoietic Agent PHARMACOLOGICAL
BARICINIX 4 MG
Product Description: Baricitinib is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded
HERNIX 40 MG
Hernix Tablet Neratinib 40 mg Beacon Pharmaceuticals Ltd. Indications Neratinib is a kinase inhibitor indicated for the extended adjuvant treatment of
Reviews
There are no reviews yet.